[1]
Karina, K. et al. 2021. Evaluating the Safety of Intravenous Delivery of Autologous Activated Platelet-rich Plasma. Journal of Health Sciences. 11, 2 (Sep. 2021), 61–65. DOI:https://doi.org/10.17532/jhsci.2021.1276.